Ryght
5 known investors
Ryght builds an AI platform for clinical trial site selection and feasibility, using "AI Site Twins" — digital replicas of clinical research sites — to analyze protocols and match sponsors and CROs with high-potential research sites worldwide. It also offers a free search engine (RyghtSites.com) covering 60,000+ global research sites, along with tools for site ranking and automated feasibility outreach.
AI & Machine LearningBiotechHealthtech
Investors · 5
Frequently asked questions
- What does Ryght do?
- Ryght builds an AI platform for clinical trial site selection and feasibility, using "AI Site Twins" — digital replicas of clinical research sites — to analyze protocols and match sponsors and CROs with high-potential research sites worldwide. It also offers a free search engine (RyghtSites.com) covering 60,000+ global research sites, along with tools for site ranking and automated feasibility outreach.
- Who are Ryght's investors?
- Ryght's investors include AIX Ventures, Foothill Ventures, Iaso Ventures, Page One Ventures, Virtue Ventures.